Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

PLSEPLSE
Showing 8 of 19 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in PULSE BIOSCIENCES INC

CITADEL ADVISORS LLC holds 626,514 shares of PLSE (PULSE BIOSCIENCES INC), worth $17.4M as of 2026-Q2. The position was increased (+340.7% shares). PLSE represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$17.4M

Current Shares

626,514

Total Value Change

+$17.4M

Total Shares Change

+626,160

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
626,514
+340.7%
$17.4M0.0%$27.73
46
2026-Q1
Increased
142,150
+242.3%
$3.1M0.0%$17.95
43
2025-Q4
Increased
41,530
+11.9%
$570,2070.0%$13.70
27
2025-Q3
Increased
37,118
+176.3%
$656,9890.0%$17.80
40
2025-Q2
Decreased
13,433
-47.7%
$202,7040.0%$15.08
0
2025-Q1
New
25,687
-
$413,3040.0%$16.60
33
2024-Q4
Exited
0
-100.0%
$00.0%$17.66
0
2024-Q3
New
354
-
$6,2090.0%$17.20
24

Other major holders of PLSE: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used